Sanofi-Aventis
Registered Principal Details
Business Or Interest:
Pharmaceuticals.
Lobbying Interests:
Health agencies.
CEO Name:
Tim Rothwell
Director, State Government Affairs
Pharmaceuticals.
Lobbying Interests:
Health agencies.
CEO Name:
Tim Rothwell
Director, State Government Affairs
Contact
KM
Kirk Morgan
55 Corporate Drive, Mail Stop 55B-230C
Bridgewater, NJ 08807-5925
(518) 669-6462
(518) 786-1904
kirk.morgan@sanofi-aventis.com
www.sanofi-aventis.us
55 Corporate Drive, Mail Stop 55B-230C
Bridgewater, NJ 08807-5925
(518) 669-6462
(518) 786-1904
kirk.morgan@sanofi-aventis.com
www.sanofi-aventis.us
Authorized Lobbyists
Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 56
Relating to: advertising for prescription drugs.
Bill Text and History
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: advertising for prescription drugs.
Bill Text and History
Against
Notification Date3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 217
Relating to: requiring health insurance coverage of colorectal cancer screening and granting rule-making authority.
Bill Text and History
4/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: requiring health insurance coverage of colorectal cancer screening and granting rule-making authority.
Bill Text and History
For
Notification Date4/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 506
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
Bill Text and History
10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
Bill Text and History
Against
Notification Date10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 198
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: donating drugs and dispensing donated drugs.
Bill Text and History
Other
Notification Date10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 354
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
Bill Text and History
10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
Bill Text and History
Against
Notification Date10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Joint Resolution 51
Relating to: proclaiming October 2009 as Breast Cancer Awareness Month.
Bill Text and History
10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: proclaiming October 2009 as Breast Cancer Awareness Month.
Bill Text and History
For
Notification Date10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Joint Resolution 52
Relating to: the life and public service of Ernest Paul Sobotta.
Bill Text and History
10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: the life and public service of Ernest Paul Sobotta.
Bill Text and History
For
Notification Date10/26/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Related to prescription drug education, marketing, and dissemination of required information
Related to prescription drug education, marketing, and dissemination of required information
Action Intended To Affect
Legislative Matter
Notification Date
3/11/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/11/2010
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Cancer Compendia
Cancer Compendia
Action Intended To Affect
Legislative Matter
Notification Date
12/14/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
12/14/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Academic detailing of pharmaceuticals
Academic detailing of pharmaceuticals
Action Intended To Affect
Legislative Matter
Notification Date
4/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
4/27/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medical assistance in state budget
Medical assistance in state budget
Action Intended To Affect
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
pharmaceuticals advertising
pharmaceuticals advertising
Action Intended To Affect
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Revision of oncology reference compendia
Revision of oncology reference compendia
Action Intended To Affect
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
3/6/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total | |
---|---|---|---|---|---|
Total Lobbying Expenditures | 2009 January - June $15,760.94 |
2009 July - December $19,809.82 |
2010 January - June $20,520.18 |
2010 July - December $1,028.04 |
Total $57,118.98 |
Total Hours Communicating | 2009 January - June 25.50 |
2009 July - December 30.50 |
2010 January - June 30.50 |
2010 July - December 2.00 |
Total 88.50 |
Total Hours Other | 2009 January - June 31.00 |
2009 July - December 20.50 |
2010 January - June 16.50 |
2010 July - December 3.00 |
Total 71.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: advertising for prescription drugs.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 20% |
2009 July - December 10% |
2010 January - June 10% |
2010 July - December |
Total 13% |
Relating to: requiring health insurance coverage of colorectal cancer screening and granting rule-making authority.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 20% |
2009 July - December 10% |
2010 January - June 15% |
2010 July - December |
Total 14% |
Relating to: donating drugs and dispensing donated drugs.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December 5% |
2010 January - June 10% |
2010 July - December |
Total 5% |
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December 5% |
2010 January - June |
2010 July - December |
Total 2% |
Relating to: substitutions by pharmacists dispensing epilepsy drugs.
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December 10% |
2010 January - June |
2010 July - December |
Total 3% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 10% |
2009 July - December 15% |
2010 January - June 10% |
2010 July - December |
Total 11% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 15% |
2009 July - December 10% |
2010 January - June 10% |
2010 July - December |
Total 11% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 15% |
2009 July - December 15% |
2010 January - June |
2010 July - December |
Total 10% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June 20% |
2009 July - December 20% |
2010 January - June |
2010 July - December |
Total 13% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December |
2010 January - June 10% |
2010 July - December |
Total 3% |
2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
---|---|---|---|---|
2009 January - June |
2009 July - December |
2010 January - June 25% |
2010 July - December 100% |
Total 11% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.